Abstract There is no generally agreed upon standard of care treatment for elderly patients (age =70 years) with glioblastoma (GBM). Treatment options range from supportive care only, radiation therapy (RT) only (most often given in a shortened hypofractionated schedule), temozolomide (TMZ) chemotherapy only, and the combination RT + TMZ, followed by post-RT TMZ as is the current standard of care for younger good performance patients with newly diagnosed GBM.
CITATION STYLE
Chamberlain, M. C. (2015). Glioblastoma in the elderly. Cancer Treatment and Research, 163, 159–170. https://doi.org/10.1007/978-3-319-12048-5_10
Mendeley helps you to discover research relevant for your work.